array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(21) "Elevance Health, Inc."
["slug"]=>
string(19) "410d3-us-anthem-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/450d7e13-9f07-44cd-ac18-ed35846aceac"
["description"]=>
string(580) "Fueled by our bold purpose to improve the health of humanity, we are transforming from a traditional health benefits organization into a lifetime trusted health partner.  
Our nearly 100,000 associates serve more than 118 million people, at every stage of health. We address a full range of needs with an integrated whole health approach, powered by industry-leading capabilities and a digital platform for health. 
We believe that improving health for everyone is possible. It begins by redefining health, reimagining the health system, and strengthening our communities."
["address_street"]=>
string(16) "220 Virginia Ave"
["address_place"]=>
string(12) "Indianapolis"
["address_region"]=>
string(7) "Indiana"
["founding_date"]=>
string(10) "1944-02-28"
["website_domain"]=>
string(18) "elevancehealth.com"
["website_url"]=>
string(30) "https://www.elevancehealth.com"
["industry_codes"]=>
array(2) {
[0]=>
string(29) "Accident and Health Insurance"
[1]=>
string(34) "Hospital and Medical Service Plans"
}
["employee_count"]=>
int(98200)
["article_count"]=>
int(548)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(70) "Trust Point Inc. Buys New Position in Elevance Health, Inc. (NYSE:ELV)"
["snippet_en"]=>
string(235) "Trust Point Inc. bought a new stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 1,080 shares of the company’s stock, valued at approximately $509,000."
["url"]=>
string(109) "https://www.defenseworld.net/2024/04/06/trust-point-inc-buys-new-position-in-elevance-health-inc-nyseelv.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/5ee41050-eb19-4f1b-a9f8-8d945dbaa934"
["source"]=>
string(16) "defenseworld.net"
["publication_date"]=>
string(10) "2024-04-06"
["categories"]=>
array(4) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(12) "Stock Market"
[2]=>
string(18) "General Investment"
[3]=>
string(24) "Stock Research & Ratings"
}
}
[1]=>
array(7) {
["title_en"]=>
string(58) "Wall Street drifts to a mixed finish as yields tick higher"
["snippet_en"]=>
string(83) "U.S. stock indexes drifted to a mixed finish on Thursday in a quiet day of trading."
["url"]=>
string(145) "https://www.detroitnews.com/story/business/2024/04/18/wall-street-ticks-higher-following-more-reports-showing-a-resilient-us-economy/73370040007/"
["image_url"]=>
NULL
["source"]=>
string(15) "detroitnews.com"
["publication_date"]=>
string(10) "2024-04-01"
["categories"]=>
array(4) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
[2]=>
string(12) "Stock Market"
[3]=>
string(15) "Market Movement"
}
}
[2]=>
array(7) {
["title_en"]=>
string(44) "Wall St ticks up on megacaps, earnings boost"
["snippet_en"]=>
string(118) "NEW YORK: Wall Street’s main stock indexes gained on Thursday as investors cheered upbeat earnings across several..."
["url"]=>
string(39) "https://www.brecorder.com/news/40299226"
["image_url"]=>
NULL
["source"]=>
string(13) "brecorder.com"
["publication_date"]=>
string(10) "2024-04-01"
["categories"]=>
array(3) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
[2]=>
string(12) "Stock Market"
}
}
[3]=>
array(7) {
["title_en"]=>
string(62) "Hardly any impetus for the Elevance Health share (€481.5755)"
["snippet_en"]=>
string(107) "Elevance Health shares are currently unremarkable in US securities trading. The security last cost $519.75."
["url"]=>
string(90) "https://www.ariva.de/news/kaum-impulse-fr-die-elevance-health-aktie-481-5755-euro-11194868"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/cdbe0258-ec44-40b5-bf38-a14c9c264154"
["source"]=>
string(8) "ariva.de"
["publication_date"]=>
string(10) "2024-03-28"
["categories"]=>
array(2) {
[0]=>
string(14) "Issuing Shares"
[1]=>
string(12) "Stock Market"
}
}
[4]=>
array(7) {
["title_en"]=>
string(55) "ELV or GDRX: Which Is the Better Value Stock Right Now?"
["snippet_en"]=>
string(53) "ELV vs. GDRX: Which Stock Is the Better Value Option?"
["url"]=>
string(73) "https://finance.yahoo.com/news/elv-gdrx-better-value-stock-154013664.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/3aa4edda-3f9a-4448-9f4a-a5c24476df62"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2024-03-22"
["categories"]=>
array(2) {
[0]=>
string(19) "Economic Conditions"
[1]=>
string(12) "Stock Market"
}
}
[5]=>
array(7) {
["title_en"]=>
string(68) "Stock Market Consulting with General Stock Market and GPM 03/20/2024"
["snippet_en"]=>
string(152) "In the Stock Market Consultancy with Bolsa General and GPM, we are joined by David Galán, from Bolsa General, and Javier Alfayate, fund manager at GPM."
["url"]=>
string(125) "https://intereconomia.com/programas/cierre-de-mercados/consultorio-de-bolsa-con-bolsa-general-y-gpm-20-03-2024-20240320-1911/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/8271618e-5cb2-44f3-af87-f8cf19a04a29"
["source"]=>
string(17) "intereconomia.com"
["publication_date"]=>
string(10) "2024-03-20"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(15) "Market Movement"
}
}
[6]=>
array(7) {
["title_en"]=>
string(82) "Sherbrooke Park Advisers LLC Buys New Position in Elevance Health, Inc. (NYSE:ELV)"
["snippet_en"]=>
string(300) "Sherbrooke Park Advisers LLC acquired a new stake in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,245 shares of the company's stock, valued at approxima"
["url"]=>
string(73) "https://www.marketbeat.com/instant-alerts/nyse-elv-sec-filing-2024-03-01/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/078848f4-f140-48d0-b2a5-95b68ad45110"
["source"]=>
string(14) "marketbeat.com"
["publication_date"]=>
string(10) "2024-03-01"
["categories"]=>
array(4) {
[0]=>
string(11) "Acquisition"
[1]=>
string(12) "Stock Market"
[2]=>
string(18) "General Investment"
[3]=>
string(11) "Regulations"
}
}
[7]=>
array(7) {
["title_en"]=>
string(75) "Elevance Health (NYSE:ELV) - Stock Price, News & Analysis - Simply Wall St"
["snippet_en"]=>
string(158) "Research Elevance Health's (NYSE:ELV) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more."
["url"]=>
string(67) "https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c7c337c9-73a9-4414-aa87-de14d88faad4"
["source"]=>
string(13) "simplywall.st"
["publication_date"]=>
string(10) "2024-02-21"
["categories"]=>
array(7) {
[0]=>
string(11) "Acquisition"
[1]=>
string(18) "General Investment"
[2]=>
string(9) "Valuation"
[3]=>
string(15) "Market Movement"
[4]=>
string(24) "Stock Research & Ratings"
[5]=>
string(12) "Stock Market"
[6]=>
string(24) "Access and affordability"
}
}
[8]=>
array(7) {
["title_en"]=>
string(77) "Elevance Health Inc. stock underperforms Tuesday when compared to competitors"
["snippet_en"]=>
string(157) "Shares of Elevance Health Inc. shed 0.73% to $508.91 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P..."
["url"]=>
string(136) "https://www.marketwatch.com/data-news/elevance-health-inc-stock-underperforms-tuesday-when-compared-to-competitors-74858d43-0ce5b4245b24"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/8d79cf3b-7a24-466c-bd1b-a9acf24c9496"
["source"]=>
string(15) "marketwatch.com"
["publication_date"]=>
string(10) "2024-02-20"
["categories"]=>
array(4) {
[0]=>
string(12) "Going Public"
[1]=>
string(12) "Stock Market"
[2]=>
string(15) "Market Movement"
[3]=>
string(24) "Stock Research & Ratings"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(96)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(61)
}
[2]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(55)
}
[3]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(30)
}
[4]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(28)
}
[5]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(23)
}
[6]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(21)
}
[8]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(20)
}
[9]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(15)
}
[10]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(15)
}
[11]=>
array(2) {
["name"]=>
string(22) "Purchasing contracting"
["count"]=>
int(13)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(12)
}
[13]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(11)
}
[14]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(10)
}
[15]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(10)
}
[16]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(10)
}
[17]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[21]=>
array(2) {
["name"]=>
string(11) "Name Change"
["count"]=>
int(8)
}
[22]=>
array(2) {
["name"]=>
string(24) "Employee Health & Safety"
["count"]=>
int(8)
}
[23]=>
array(2) {
["name"]=>
string(15) "Blogs & Columns"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(7)
}
[26]=>
array(2) {
["name"]=>
string(19) "Under Investigation"
["count"]=>
int(7)
}
[27]=>
array(2) {
["name"]=>
string(7) "Opening"
["count"]=>
int(6)
}
[28]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(6)
}
[29]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(6)
}
}
}
410d3-us-anthem-inc
Elevance Health, Inc.
Location
Indiana
Founded
1944-02-28
Website
https://www.elevancehealth.com
Articles
548 Articles
Category
Accident and Health Insurance
Hospital and Medical Service Plans
Description
Fueled by our bold purpose to improve the health of humanity, we are transforming from a traditional health benefits organization into a lifetime trusted health partner.  
Our nearly 100,000 associates serve more than 118 million people, at every stage of health. We address a full range of needs with an integrated whole health approach, powered by industry-leading capabilities and a digital platform for health. 
We believe that improving health for everyone is possible. It begins by redefining health, reimagining the health system, and strengthening our communities.
Trust Point Inc. bought a new stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 1,080 shares of the company’s stock, valued at approximately $509,000.
In the Stock Market Consultancy with Bolsa General and GPM, we are joined by David Galán, from Bolsa General, and Javier Alfayate, fund manager at GPM.
Sherbrooke Park Advisers LLC acquired a new stake in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,245 shares of the company's stock, valued at approxima
Research Elevance Health's (NYSE:ELV) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.
Shares of Elevance Health Inc. shed 0.73% to $508.91 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
